News
CCEL
3.870
-3.35%
-0.134
Weekly Report: what happened at CCEL last week (1201-1205)?
Weekly Report · 6d ago
Weekly Report: what happened at CCEL last week (1124-1128)?
Weekly Report · 12/01 09:56
Weekly Report: what happened at CCEL last week (1117-1121)?
Weekly Report · 11/24 10:00
Weekly Report: what happened at CCEL last week (1110-1114)?
Weekly Report · 11/17 10:00
Cryo-Cell International Halts Q4 2025 Dividend Declaration
TipRanks · 11/12 22:42
Weekly Report: what happened at CCEL last week (1103-1107)?
Weekly Report · 11/10 09:58
Weekly Report: what happened at CCEL last week (1027-1031)?
Weekly Report · 11/03 09:58
Weekly Report: what happened at CCEL last week (1020-1024)?
Weekly Report · 10/27 10:01
Cryo-Cell International Amends Credit Agreement with Susser Bank
TipRanks · 10/23 21:32
Cryo-Cell International Cut to Hold From Buy by Maxim Group
Dow Jones · 10/20 13:30
Maxim Group Downgrades Cryo-Cell International to Hold
Benzinga · 10/20 13:20
Cryo-Cell downgraded to Hold from Buy at Maxim
TipRanks · 10/20 11:50
Weekly Report: what happened at CCEL last week (1013-1017)?
Weekly Report · 10/20 09:58
CRYO-CELL International GAAP EPS of $0.09, revenue of $7.83M
Seeking Alpha · 10/16 17:57
CRYO-CELL INTERNATIONAL, INC. (Form 10-Q)
Press release · 10/16 04:10
Cryo-Cell International Inc Q3 Profit Drops
NASDAQ · 10/16 00:38
*Cryo-Cell International 3Q EPS 9c >CCEL
Dow Jones · 10/15 21:01
*Cryo-Cell International 3Q Rev $7.83M >CCEL
Dow Jones · 10/15 21:01
Press Release: Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results
Dow Jones · 10/15 21:00
Weekly Report: what happened at CCEL last week (1006-1010)?
Weekly Report · 10/13 10:00
More
Webull provides a variety of real-time CCEL stock news. You can receive the latest news about Cryo-Cell Intl Inc through multiple platforms. This information may help you make smarter investment decisions.
About CCEL
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 240,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.